Hematopoietic stem cell transplantation for cardiac and peripheral vascular disease.
Bone Marrow Transplant
; 32 Suppl 1: S29-31, 2003 Aug.
Article
en En
| MEDLINE
| ID: mdl-12931237
ABSTRACT
Recent studies have suggested that marrow and blood hematopoietic stem cells may contribute to nonhematopoietic tissue repair in multiple organ systems. In animal models and more recently in limited human trials, unpurified marrow mononuclear cells and/or subsets of adult hematopoietic stem cells have been reported to contribute to neoangiogenesis. Since the subset of hematopoietic stem cells (HSCs) that are both CD34+ and AC133+ are endothelial cell precursors, clinical trials using autologous AC133+ HSCs isolated with the Miltenyi CLIMACS cell separator and transplanted into patients with ischemic and refractory peripheral vascular or coronary artery disease are being implemented at Northwestern University.
Buscar en Google
Base de datos:
MEDLINE
Asunto principal:
Enfermedades Cardiovasculares
/
Enfermedades Vasculares Periféricas
/
Trasplante de Células Madre Hematopoyéticas
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Bone Marrow Transplant
Asunto de la revista:
TRANSPLANTE
Año:
2003
Tipo del documento:
Article
País de afiliación:
Estados Unidos